- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Pricing
- SKY Learn
- Mutual Funds
- Margin Trading
- Financial Planning
- Personal Finance
- Share Trading
- IPO
- Derivatives
- Currencies
- Intraday Trading
- Trading Strategies
- Demat Account
- Commodity
- ETF
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Divi's Laboratories Share Price
Divi's Laboratories Ltd.
₹5,912.50
-34.50(-0.58%)
Invest in DIVISLAB with up to 2.86x margin.
Trade with MTF1st Apr 2026 | 1:15 PM
NSE : DIVISLAB
Open Free Demat Account
Divi's Laboratories Performance
Price Movement
₹5912.50
₹5834.00
₹6123.00
↘ Today's Low↗ Today's High
1 Year Performance
₹5912.50
₹4955.00
₹7071.50
↘ 52 Week Low↗ 52 Week High
Markets Today
High₹6,123.00
Low₹5,834.00
Open at₹6,002.00
Prev Close₹5,947.00
Volumes2.62 L
Avg Price₹5,996.98
Lower Circuit₹5,352.50
Upper Circuit₹6,541.50
Historical Performance
3M High₹6,793.00
3M Low₹5,890.00
1 Yr High₹7,071.50
1 Yr Low₹4,955.00
3 Yr High₹7,071.50
3 Yr Low₹2,810.80
5 Yr High₹7,071.50
5 Yr Low₹2,730.00
Divi's Laboratories Fundamentals
Market Cap
Market Runner Up
1,57,874.20 Cr.
PE Ratio (TTM)
High in industry
63.70
Dividend Yield
Below industry Median
0.50
Net Profit TTM
19.9% incr over last year
2,479
Net Profit Growth
19.9% incr over last year
2,479
PEG Ratio
High in industry
3.20
ROE
24.2% incr over last year
14.63
Operating Revenue TTM
10,314
Operating Revenue Growth
13.6% incr over last year
Book Value
High in industry
9.90
MFI
MFI is mid-range
38.81
RSI
RSI is mid-range
37.22
EPS (TTM)
82.53
Debt to Equity
0
Face Value
2
Operating Profit Margin Qtr.
30.56
Operating Profit Qtr.
890
Net Profit Qtr.
583
Operating Revenue Qtr.
2,604
PB Ratio
9.90
Divi's Laboratories Financials
*All values are in Rs. Cr
Loading chart...
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 2,578 | 2,660 | 2,357 | 2,536 | 2,297 |
| Operating Expense | 1,671 | 1,765 | 1,614 | 1,655 | 1,550 |
| Operating Profit | 907 | 895 | 743 | 881 | 747 |
| Depreciation | 116 | 113 | 112 | 107 | 99 |
| Interest | 6 | 8 | 3 | 0 | 0 |
| Tax | 200 | 224 | 190 | 194 | 136 |
| Net Profit | 598 | 696 | 557 | 667 | 594 |
DIVISLAB Stock Recommendation by HDFC
Research Type
Equity , Long Term
Buy Range
₹6,363 - ₹0
Target Price
₹7,630
Stop Loss
-
Target Date
7 Jan 27
Potential Returns
19.91 %
Divi's Laboratories Technicals
Divi's Laboratories Ltd. EMA & SMA
₹5912.50
-85.00 (-1.42%)
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
Day EMA5 ₹5999.7
Day EMA10 ₹6050.5
Day EMA12 ₹6068.8
Day EMA20 ₹6121.2
Day EMA26 ₹6145.4
Day EMA50 ₹6201.7
Day EMA100 ₹6254.2
Day EMA200 ₹6220
Divi's Laboratories Support and Resistance
Resistance
First Resistance₹5990.83
Second Resistance₹6034.67
Third Resistance₹6079.33
Support
First Support₹5902.33
Second Support₹5857.67
Third Support₹5813.83
Technical Indicators
Day RSI37.22
Day MFI38.81
Day ADX19.97
Day Commodity Channel Index-108.50
William-92.12
Day MACD-76.56
Day MACD Signal Line-50.75
Day ATR149.22
Day ROC1250.85
Day ROC21-7.01
Divi's Laboratories Shareholding Pattern
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 51.9 | 51.9 | 51.9 | 51.9 | 51.9 | 51.9 |
| FII | 17.2 | 18 | 18 | 19.7 | 19.4 | 20.1 |
| DII | 21.1 | 20.5 | 20.7 | 19.1 | 19.8 | 19.3 |
| Public | 9.8 | 9.6 | 9.4 | 9.3 | 9 | 8.8 |
Divi's Laboratories Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.5 L | 5.02 L | 49.82% |
| Week | 2.25 L | 3.86 L | 58.34% |
| 1 Month | 1.68 L | 2.94 L | 57.25% |
| 6 Month | 2.12 L | 3.8 L | 55.82% |
Divi's Laboratories SWOT Analysis
Strengths8
Weakness11
Opportunity2
Threats1
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Volume Shockers
Divi's Laboratories Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 25 Jul, 2025 | 30 | FINAL | 25 Jul, 2025 | Equity Share |
| 02 Aug, 2024 | 30 | FINAL | 02 Aug, 2024 | Equity Share |
| 11 Aug, 2023 | 30 | FINAL | 11 Aug, 2023 | Equity Share |
| 11 Aug, 2022 | 30 | FINAL | 12 Aug, 2022 | Equity Share |
| 17 Aug, 2021 | 20 | FINAL | Equity Share | |
| 25 Feb, 2020 | 16 | INTERIM | 26 Feb, 2020 | Equity Share |
| 14 Aug, 2019 | 16 | FINAL | Equity Share | |
| 31 Aug, 2018 | 10 | FINAL | Equity Share | |
| 15 Sep, 2017 | 10 | FINAL | Equity Share | |
| 17 Mar, 2016 | 10 | INTERIM | 18 Mar, 2016 | Equity Share |
Divi's Laboratories Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹673.60 | ₹967.85 | ₹1,596.80 | ₹1,999.70 | ₹1,725.10 | ₹1,035.50 |
| % Change | 2.64% | -0.43% | 0.08% | -0.30% | 1.71% | 4.31% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹2,169.86 | ₹8,850.08 | ₹13,914.08 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹332.94 | ₹869.92 | ₹1,779.35 | ₹847.18 | ₹843.32 |
| PE TTM | 76.10 | 61.80 | 34.80 | 46.50 | 33.00 | 63.50 |
| 1 Year Return | 15.13 | 27.75 | 48.78 | -17.28 | 6.51 | 61.84 |
| ROCE | 26.88 | 12.51 | 20.80 | 13.27 | 11.43 | 11.82 |
Similar Stocks
ALKEM
Alkem Laboratories Ltd.
₹ 5264.00
-0.66%
BIOCON
Biocon Ltd.
₹ 369.25
+2.31%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 2828.90
+0.85%
ZYDUSLIFE
Zydus Lifesciences Ltd.
₹ 873.60
+0.28%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2119.50
-0.57%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1344.40
+3.07%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1729.90
-1.55%
IPCALAB
Ipca Laboratories Ltd.
₹ 1561.90
-2.45%
JBCHEPHARM
J B Chemicals & Pharmaceuticals Ltd.
₹ 2009.60
-2.65%
ASTRAZEN
AstraZeneca Pharma India Ltd.
₹ 7867.00
+1.31%
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2335.60
+2.30%
PFIZER
Pfizer Ltd.
₹ 4833.30
+2.39%
ABBOTINDIA
Abbott India Ltd.
₹ 26405.00
+1.89%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 4153.40
-1.58%
LUPIN
Lupin Ltd.
₹ 2281.20
-1.41%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1228.00
-2.14%
CIPLA
Cipla Ltd.
₹ 1201.60
-1.85%
FAQ's on DIVISLAB
What is the current share price of Divi's Laboratories Ltd.?
As of 6 June 2025 at 10:01 AM, the share price for Divi's Laboratories Ltd. is ₹ 5912.5 on the NSE and ₹ 5913.05 on the BSE. (Note: Prices are dynamic and update frequently during market hours).
What is the Market Capitalization of Divi's Laboratories Ltd.?
Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Divi's Laboratories Ltd. is approximately ₹ 157874.2 Cr.
What are the PE and PB ratios for Divi's Laboratories Ltd.?
Based on recent data, the Price-to-Earnings (PE) ratio for Divi's Laboratories Ltd. is 63.7, and the Price-to-Book (PB) ratio is 9.9.
What is the 52-Week High and Low for Divi's Laboratories Ltd.?
Over the past 52 weeks, the highest price reached by Divi's Laboratories Ltd. shares was ₹ 7071.5, and the lowest price was ₹ 4955.
What is the current dividend yield for Divi's Laboratories Ltd.?
As of 6 June 2025, the dividend yield for Divi's Laboratories Ltd. is 0.5%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.
Who are the major shareholders of Divi's Laboratories Ltd.?
Significant shareholdings in Divi's Laboratories Ltd. typically include entities such as:
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
- Promoter
- FII
- Mutual Funds
- Public
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Divi's Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?
In the Pharmaceuticals & Biotechnology sector, Divi's Laboratories Ltd. is often compared with other major players such as
Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.
What is the latest dividend information for Divi's Laboratories Ltd.?
Divi's Laboratories Ltd. last declared a FINAL dividend of ₹ 30 per share for the financial period ending 2025. The record date was set as 2025-07-25, and the payment was/is scheduled around 2025-07-25. For the most current dividend announcements, refer to official company filings.
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy